Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action degraders |
Mechanism STING degraders(Stimulator of interferon genes degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H42Cl2N8O9 |
InChIKeyFGTYORLXIPLJJD-UHFFFAOYSA-N |
CAS Registry3098871-32-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | China | 12 May 2025 | |
| Autoimmune Diseases | Preclinical | China | 12 May 2025 | |
| Inflammation | Preclinical | China | 12 May 2025 | |
| Inflammation | Preclinical | China | 12 May 2025 |





